{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T04:12:18Z","timestamp":1768795938723,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2017R1D1A1B03029050"],"award-info":[{"award-number":["2017R1D1A1B03029050"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"publisher","award":["6-2016-0159"],"award-info":[{"award-number":["6-2016-0159"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008377","name":"Handok","doi-asserted-by":"publisher","award":["HANDOK-2017-005"],"award-info":[{"award-number":["HANDOK-2017-005"]}],"id":[{"id":"10.13039\/100008377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea government (MSIP)","award":["NRF-2017R1A2B4002968"],"award-info":[{"award-number":["NRF-2017R1A2B4002968"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.biomaterials.2019.119408","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T07:04:02Z","timestamp":1564729442000},"page":"119408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB\/NZW) F1 mice"],"prefix":"10.1016","volume":"220","author":[{"given":"Chin Hee","family":"Mun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Ock","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Soo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taejun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunhee","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Dong","family":"Noh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Beom","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hak-Jun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Gyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2019.119408_bib1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2019.119408_bib2","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013010026","article-title":"The pathogenesis of lupus nephritis","volume":"24","author":"Lech","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.kint.2016.05.017","article-title":"A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis","volume":"90","author":"Anders","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.biomaterials.2019.119408_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrneph.2017.85","article-title":"Redefining lupus nephritis: clinical implications of pathophysiologic subtypes","volume":"13","author":"Yu","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/BOR.0000000000000082","article-title":"The role of T cells in systemic lupus erythematosus: an update","volume":"26","author":"Konya","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib6","first-page":"980286","article-title":"Th subset balance in lupus nephritis","volume":"2011","author":"Miyake","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/nep.12047","article-title":"The role of cytokines in the pathogenesis of systemic lupus erythematosus - from bench to bedside","volume":"18","author":"Yap","year":"2013","journal-title":"Nephrology"},{"key":"10.1016\/j.biomaterials.2019.119408_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clim.2016.09.002","article-title":"Anti-dsDNA antibodies and resident renal cells - their putative roles in pathogenesis of renal lesions in lupus nephritis","volume":"185","author":"Yung","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib9","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/art.37955","article-title":"Soluble receptor for advanced glycation end products alleviates nephritis in (NZB\/NZW) F1 mice","volume":"65","author":"Lee","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biomaterials.2019.119408_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/0961203308100481","article-title":"European consensus statement on the terminology used in the management of lupus glomerulonephritis","volume":"18","author":"Gordon","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.biomaterials.2019.119408_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.semarthrit.2018.01.001","article-title":"Systematic review, and meta-analysis of steroid-sparing effect, of biologic agents in randomized, placebo-controlled phase 3 trials for systemic lupus erythematosus","volume":"48","author":"Oon","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.biomaterials.2019.119408_bib12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3899\/jrheum.121368","article-title":"Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus","volume":"41","author":"Ginzler","year":"2014","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib13","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/annrheumdis-2012-202865","article-title":"Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials","volume":"73","author":"Strand","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biomaterials.2019.119408_bib14","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1056\/NEJMct1207259","article-title":"Belimumab for systemic lupus erythematosus","volume":"368","author":"Hahn","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2019.119408_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/iub.324","article-title":"Aminoacyl-tRNA synthetase-interacting multifunctional proteins (AIMPs): a triad for cellular homeostasis","volume":"62","author":"Park","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.biomaterials.2019.119408_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0002-9440(10)62262-6","article-title":"The novel cytokine p43 stimulates dermal fibroblast proliferation and wound repair","volume":"166","author":"Park","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib17","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.4049\/jimmunol.180.5.2894","article-title":"AIMP1\/p43 protein induces the maturation of bone marrow-derived dendritic cells with T helper type 1-polarizing ability","volume":"180","author":"Kim","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib18","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.4049\/jimmunol.1601558","article-title":"Aminoacyl tRNA synthetase-interacting multifunctional protein 1 activates NK cells via macrophages in vitro and in vivo","volume":"198","author":"Kim","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib19","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.4049\/jimmunol.1401352","article-title":"Aminoacyl tRNA synthetase-interacting multifunctional protein 1 acts as a novel B cell-activating factor in vitro and in vivo","volume":"194","author":"Kim","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.biomaterials.2014.12.017","article-title":"The antibody atliximab attenuates collagen-induced arthritis by neutralizing AIMP1, an inflammatory cytokine that enhances osteoclastogenesis","volume":"44","author":"Hong","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2019.119408_bib21","first-page":"533","article-title":"Serum aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1), a novel disease activity predictive biomarker of systemic lupus erythematosus","volume":"36","author":"Ahn","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib22","first-page":"271694","article-title":"Murine models of systemic lupus erythematosus","volume":"2011","author":"Perry","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib23","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/0300985810370005","article-title":"Mouse models of systemic lupus erythematosus reveal a complex pathogenesis","volume":"47","author":"Rottman","year":"2010","journal-title":"Vet Pathol"},{"key":"10.1016\/j.biomaterials.2019.119408_bib24","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.kint.2017.11.017","article-title":"Intranuclear delivery of the transcription modulation domain of Tbet-improved lupus nephritis in (NZB\/NZW) F1 lupus-prone mice","volume":"93","author":"Moon","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.biomaterials.2019.119408_bib25","first-page":"i32","article-title":"Systemic lupus erythematosus biomarkers: the challenging quest","volume":"56","author":"Arriens","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.biomaterials.2019.119408_bib26","doi-asserted-by":"crossref","first-page":"25106","DOI":"10.1016\/S0021-9258(17)31505-3","article-title":"Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II","volume":"269","author":"Kao","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biomaterials.2019.119408_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/(SICI)1098-1136(199708)20:4<365::AID-GLIA8>3.0.CO;2-4","article-title":"Localization of endothelial-monocyte-activating polypeptide II (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: expression by monocytes and activated microglial cells","volume":"20","author":"Schluesener","year":"1997","journal-title":"Glia"},{"key":"10.1016\/j.biomaterials.2019.119408_bib28","doi-asserted-by":"crossref","first-page":"419029","DOI":"10.1155\/2014\/419029","article-title":"The pathology of T cells in systemic lupus erythematosus","volume":"2014","author":"Mak","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.biomaterials.2019.119408_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.immuni.2016.12.014","article-title":"Follicular dendritic cell activation by TLR ligands promotes autoreactive B cell responses","volume":"46","author":"Das","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2019.119408_bib30","doi-asserted-by":"crossref","first-page":"457146","DOI":"10.1155\/2010\/457146","article-title":"Cytokine overproduction, T-cell activation, and defective T-regulatory functions promote nephritis in systemic lupus erythematosus","volume":"2010","author":"Tucci","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib31","doi-asserted-by":"crossref","first-page":"14023","DOI":"10.1073\/pnas.0806726105","article-title":"TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3","volume":"105","author":"Samanta","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2019.119408_bib32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.immuni.2014.06.011","article-title":"Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells","volume":"41","author":"Wu","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2019.119408_bib33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3892\/ijo.2015.3303","article-title":"Aminoacyl-tRNA synthetase interacting multi-functional protein 1 attenuates liver fibrosis by inhibiting TGF\u03b2 signaling","volume":"48","author":"Ahn","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.immuni.2015.06.010","article-title":"Smad2 and Smad3 inversely regulate TGF-\u03b2 autoinduction in Clostridium butyricum-activated dendritic cells","volume":"43","author":"Kashiwagi","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2019.119408_bib35","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/BOR.0000000000000089","article-title":"The pathogenesis, diagnosis and treatment of lupus nephritis","volume":"26","author":"Schwartz","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/BOR.0b013e32832efff1","article-title":"Pathogenesis of kidney disease in systemic lupus erythematosus","volume":"21","author":"Bagavant","year":"2009","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cei.12296","article-title":"Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks","volume":"179","author":"Rekvig","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib38","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1080\/1744666X.2017.1366855","article-title":"Lupus nephritis and B-cell targeting therapy","volume":"13","author":"Cassia","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib39","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1084\/jem.20052438","article-title":"TLR9\/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE","volume":"203","author":"Ehlers","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biomaterials.2019.119408_bib40","doi-asserted-by":"crossref","first-page":"953","DOI":"10.5301\/jn.5000272","article-title":"NF-\u03baB and systemic lupus erythematosus: examining the link","volume":"26","author":"Zubair","year":"2013","journal-title":"J. Nephrol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib41","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/rheumatology\/kes227","article-title":"Attenuation of nephritis in lupus-prone mice by thalidomide","volume":"51","author":"Lee","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.biomaterials.2019.119408_bib42","first-page":"393","article-title":"Comparison of therapeutic efficacy between bortezomib and combination treatment of prednisolone and mycophenolate mofetil on nephritis in NZB\/WF1 mice","volume":"28","author":"Lee","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.biomaterials.2019.119408_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2567.2011.03468.x","article-title":"Enhancement of toll-like receptor 2-mediated immune responses by AIMP1, a novel cytokine, in mouse dendritic cells","volume":"134","author":"Kim","year":"2011","journal-title":"Immunology"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961219305071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961219305071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:43:42Z","timestamp":1758905022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961219305071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":43,"alternative-id":["S0142961219305071"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119408","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB\/NZW) F1 mice","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119408"}}